Loading...
OTCM
RSCF
Market cap4mUSD
Jun 10, Last price  
0.05USD
1D
-3.35%
1Q
1.76%
Jan 2017
-13.50%
IPO
-96.54%
Name

Reflect Scientific Inc

Chart & Performance

D1W1MN
P/E
—
P/S
4.12
EPS
—
Div Yield, %
—
Shrs. gr., 5y
2.69%
Rev. gr., 5y
-6.99%
Revenues
1m
-47.08%
2,103,3392,241,0692,572,9558,020,26610,126,8055,658,1252,401,6851,987,3401,329,0541,287,0231,527,9271,037,3241,188,6101,065,7771,551,9851,609,2412,792,6232,814,6702,041,2971,080,154
Net income
-459k
L
42,62738,163-978,630-7,076,619-2,164,396-4,881,878-1,772,247-1,186,975200,917-1,013,198-840,809835,937-216,196-402,189-249,523-196,343660,115939,06589,396-459,028
CFO
-104k
L+13.02%
-41,523-19,601-1,297,147-1,930,313-286,105-275,130195,839130,279-91,114-55,625109,84031,913-18,727-28,106-14,559335,869-25,218831,382-91,997-103,976
Earnings
Aug 11, 2025

Profile

Reflect Scientific, Inc. designs, develops, and sells scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as filtration and purification products, customized sample handling vials, electronic wiring assemblies, high temperature silicone, and graphite and vespel/graphite sealing components for use by original equipment manufacturers in the field of gas/liquid chromatography in the chemical analysis industries. In addition, the company offers solvent chillers and refrigerated transportation products. It serves hospitals diagnostic laboratories, pharmaceutical and biotech companies, universities, government, and private sector research facilities, as well as cold chain management, chemical, and industrial companies. Reflect Scientific, Inc. is based in Orem, Utah.
URL
https://www.reflectscientific.com/
IPO date
Jun 26, 2001
Employees
7
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,080
-47.08%
2,041
-27.48%
Cost of revenue
902
1,951
Unusual Expense (Income)
NOPBT
178
90
NOPBT Margin
16.50%
4.41%
Operating Taxes
312
702
Tax Rate
0.18%
0.78%
NOPAT
178
89
Net income
(459)
-613.48%
89
-90.48%
Dividends
Dividend yield
Proceeds from repurchase of equity
4
2
BB yield
-0.08%
-0.04%
Debt
Debt current
125
57
Long-term debt
423
115
Deferred revenue
Other long-term liabilities
92
Net debt
(730)
(1,210)
Cash flow
Cash from operating activities
(104)
(92)
CAPEX
Cash from investing activities
Cash from financing activities
2
FCF
230
(63)
Balance
Cash
1,278
1,382
Long term investments
Excess cash
1,224
1,280
Stockholders' equity
(18,410)
(17,956)
Invested Capital
20,608
20,310
ROIC
0.87%
0.44%
ROCE
8.11%
3.83%
EV
Common stock shares outstanding
85,218
85,441
Price
0.07
8.48%
0.06
-48.87%
Market cap
5,667
8.20%
5,238
-48.45%
EV
4,937
4,028
EBITDA
240
146
EV/EBITDA
20.59
27.53
Interest
Interest/NOPBT